Congenital Central Hypoventilation Syndrome

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AB
AP BiosciencesTaiwan - Taipei
1 program
CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)N/A1 trial
Active Trials
NCT06554275RecruitingEst. Aug 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
AP BiosciencesCCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

Clinical Trials (1)

NCT06554275AP BiosciencesCCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

Start: Sep 2024Est. completion: Aug 2028
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space